Persistent Asset Partners LTD Options Holdings

Persistent Asset Partners LTD

  • $119 Billion
  • Q1 2025

Options Holdings Table

Stock Option Type Value Options Held Last Trade Trade History
Soleno Therapeutics Inc
CALL
$855 Million
508
Q1 2025
New holding
Amgen Inc
CALL
$618 Million
239
Q1 2025
New holding
Corcept Therapeutics Inc
CALL
$414 Million
92
Q1 2025
New holding
Keros Therapeutics Inc
PUT
$381 Million
153
Q1 2025
New holding
Vaxcyte Inc
PUT
$335 Million
119
Q1 2025
New holding
Ultragenyx Pharmaceutical In
PUT
$258 Million
320
Q1 2025
New holding
Apogee Therapeutics Inc
CALL
$233 Million
293
Q1 2025
New holding
Bridgebio Pharma Inc
CALL
$224 Million
303
Q1 2025
New holding
Eli Lilly & CO
PUT
$215 Million
48
Q1 2025
New holding
Moderna Inc
PUT
$152 Million
230
Q1 2025
New holding
Jazz Pharmaceuticals PLC
CALL
$158 Million
163
Q1 2025
New holding
Mereo Biopharma Group PLC
CALL
$147 Million
1.19K
Q1 2025
New holding
Biomea Fusion Inc
PUT
$126 Million
406
Q1 2025
New holding
Novo Nordisk A S
PUT
$122 Million
287
Q1 2025
New holding
Regeneron Pharmaceuticals
PUT
$112 Million
46
Q1 2025
New holding
Gossamer Bio Inc
CALL
$80 Million
1.93K
Q1 2025
New holding
Recursion Pharmaceuticals In
CALL
$79.9 Million
1.61K
Q1 2025
New holding
Eli Lilly & CO
CALL
$70.2 Million
23
Q1 2025
New holding
Ocular Therapeutix Inc
CALL
$69.9 Million
313
Q1 2025
New holding
Edgewise Therapeutics Inc
CALL
$75 Million
226
Q1 2025
New holding
Cogent Biosciences Inc
PUT
$72 Million
479
Q1 2025
New holding
Zymeworks Inc
CALL
$56.9 Million
418
Q1 2025
New holding
Mannkind Corp
CALL
$53.9 Million
1.2K
Q1 2025
New holding
Agios Pharmaceuticals Inc
CALL
$64.7 Million
310
Q1 2025
New holding
Ultragenyx Pharmaceutical In
CALL
$61 Million
270
Q1 2025
New holding
Altimmune Inc
CALL
$65.2 Million
961
Q1 2025
New holding
NVO
Novo Nordisk A S

Healthcare
CALL
$52.2 Million
230
Q1 2025
Reduced 57.09%
KRE
Spdr S&P Regional Banking ETF

ETFs
CALL
$47.1 Million
1.52K
Q1 2025
Added 144.37%
Pfizer Inc
CALL
$53.4 Million
2.09K
Q1 2025
New holding
Alnylam Pharmaceuticals Inc
PUT
$43 Million
46
Q1 2025
New holding
Uniqure Nv
CALL
$42.8 Million
354
Q1 2025
New holding
Nektar Therapeutics
CALL
$36.7 Million
1.56K
Q1 2025
New holding
Crispr Therapeutics Ag
CALL
$36.5 Million
258
Q1 2025
New holding
Kalvista Pharmaceuticals Inc
CALL
$32.5 Million
241
Q1 2025
New holding
Spdr S&P 500 ETF Tr
PUT
$21.5 Million
55
Q1 2025
New holding
Amicus Therapeutics Inc
CALL
$23.5 Million
303
Q1 2025
New holding
Cardiff Oncology Inc
CALL
$26.4 Million
479
Q1 2025
New holding
Evolus Inc
PUT
$10.6 Million
115
Q1 2025
New holding
Moderna Inc
CALL
$17.1 Million
134
Q1 2025
New holding
Corcept Therapeutics Inc
PUT
$13.2 Million
346
Q1 2025
New holding
Atyr Pharma Inc
CALL
$17.9 Million
126
Q1 2025
New holding
Compass Therapeutics Inc
CALL
$13.1 Million
459
Q1 2025
New holding
Mereo Biopharma Group PLC
PUT
$7.64 Million
91
Q1 2025
New holding
Keros Therapeutics Inc
CALL
$10.8 Million
354
Q1 2025
New holding
Summit Therapeutics Inc
CALL
$12.8 Million
60
Q1 2025
New holding
Soleno Therapeutics Inc
PUT
$12.7 Million
533
Q1 2025
New holding
Relay Therapeutics Inc
CALL
$9.85 Million
303
Q1 2025
New holding
Unity Biotechnology Inc
PUT
$15.5 Million
511
Q1 2025
New holding
Unity Biotechnology Inc
CALL
$6.06 Million
801
Q1 2025
New holding

Summary

  • Portfolio
  • No. of Stocks 200
  • Current Value $119 Billion
  • Prior Value $121 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 13, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 48 stocks
  • Additional Purchases 25 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 30 stocks
Track This Portfolio

Track Persistent Asset Partners LTD Portfolio

Follow Persistent Asset Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Persistent Asset Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Persistent Asset Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email